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Background 
Mastitis is the most frequent and 
costly disease in dairy cattle 
  
Multiple forms : from clinical to sub-clinical cases, from 
acute mastitis to chronic mastitis, recovery or not 
 
Mastitis affects the milk production of the cow as well 
as the milk composition and quality 
 
Somatic cells count (SCC) is the most used indicator 
in milk  
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Objectives 
Udder health management at individual and herd level 
  early detection of mastitis 
  identification of cows suffering from chronic 
infections 
 
  1. Define the different mastitis cases 
2. Describe changes in milk composition which occur during 
clinical mastitis 
3. Investigate the potential of milk composition to provide 
early indicator of mastitis 
early indicators of recovery 
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Data and editing 
Clinical cases of mastitis are voluntary 
recorded by farmers in commercial farms 
from the Walloon Region of Belgium 
involved in the DHI program 
 
   Recording period of the herd ≥ 180d 
 No. of cows with clinical mastitis cases / total no. of cows within the herd 
over the period > 5% 
 Only lactations that started after the beginning of the recording period 
 Test-day from the recording period and from the 305 first days of lactation 
  
44,644 test-day from 7,878 lactations 
4,960 cows from 49 herds 
  23% of the lactations experienced at least 
one clinical mastitis event 
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Definitions of mastitis trait 
5 groups of mastitis were defined within the edited dataset : 
1. Healthy (Healthy) 
2. New clinical mastitis (CL-NEW) 
 Cure or no cure 
3. Chronic clinical mastitis (CL-CH) 
 Cure or no cure 
4. New sub-clinical mastitis (SUBCL-NEW) 
5. Chronic sub-clinical mastitis (SUBCL-CH) 
 
  
SCC thresholds considered to define sub-clinical cases  
  1st parity : SCC ≥ 150,000 
  2nd and+ parity : SCC ≥ 250,000 
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Definitions of mastitis trait 
Calving 
Clinical mastitis 
TD from 10 to 45 days before? 
 SCC < threshold  CL-NEW 
 SCC ≥ threshold  CL-CH 
  
TD from 15 to 45 days after? 
 SCC < threshold  
 CL-NEW with cure 
 CL-CH with cure 
 SCC ≥ threshold  
 CL-NEW without cure 
 CL-CH without cure 
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Definitions of mastitis trait 
Calving 
Only one TD with SCC ≥ threshold  SUBCL-NEW
  
Calving 
2 consecutive TD with SCC ≥ threshold  SUBCL-CH
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Definitions of mastitis trait 
Udder health status 
group 
N % 
Healthy 1,987 38.4 
CL-NEW 243 4.6 
CL-CH 480 9.2 
SUBCL-NEW 1,499 28.9 
SUBCL-CH 982 18.9 
Distribution of lactations (5,191) according 
to the udder health status group in our 
dataset 
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Changes in milk during mastitis? 
Calving 
TD from 45 to 10d. 
before 
TD from 10d. before to 10d. after 
mastitis event 
Clinical mastitis 
Comparisons using paired t-test 
 162 data 
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(1) RSQCV : R squared of cross-validation for milk components predicted by MIR 
(2) SCC and SCS were not predicted by MIR 













Fat (%) 1.187 0.0128 
Protein (%) 0.806 0.0002 
SCC(2) 818.3 < 0.0001 
SCS(2,3) 1.620 < 0.0001 
Lactoferrin (mg/L) 0.71 39.57 < 0.0001 
Casein (g/100g) 0.94 0.0425 0.0131 
Saturated FA (g/dL) 0.99 0.1480 < 0.0001 
Short chain FA (g/dL) 0.94 0.0118 0.0094 
Medium chain FA (g/dL) 0.97 0.1395 <0 .0001 
Na (mg/kg) 0.49 10.59 0.0045 
Mg  (mg/kg) 0.68 1.381 0.0212 
K  (mg/kg) 0.54 -22.75 0.0039 
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(1) RSQCV : R squared of cross-validation for milk components predicted by MIR 
(2) SCC and SCS were not predicted by MIR 
(3) SCS is the logarithmic transformation of SCC 
 ↗ SCC and SCS 
SCC is a reflection of 
the inflammatory 
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Changes in milk during mastitis? 
 ↗ Lactoferrin content 
Lactoferrin is an 
important host 
defence molecule 
 role in the defence 
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Changes in milk during mastitis? 
 ↗ Na but not highly 
significant 
Na is linked with the 
conductivity 
Conductivity is used in 
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Early indicators in milk? 
Calving 
Clinical mastitis 
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Early indicators in milk? 
  healthy   before a mastitis   
Trait N Mean Std   N Mean Std p-value 
Na (mg/kg) 1,834 347.0 49.4 1,148 359.8 57.3 <0.0001 
Lactoferrin 
(mg/l) 
1,589 159.5 74.0 988 170.0 73.5 0.0005 
Titrable acidity 
(dornic degree) 
1,789 16.6 1.5 1,115 16.5 1.5 0.0853 
Urea (mg/l) 1,846 248.8  83.9   1,154 240.7 80.7 0.0095 
Comparisons of milk composition data from a TD 
occurring before (from 10 to 45d.) a mastitis event 
(clinical and sub-clinical cases) and milk 
composition data from healthy lactations 
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Conclusion 
Milk composition predicted by MIR significantly different 
before and during a mastitis event 
 
  MIR predicted traits such as urea, Na, lactoferrine, and 
titrable acidity were identified as potential early 
indicators of udder health 
 
  
No significant differences were observed between milk 
composition data of cows that recovered from clinical 
mastitis and milk composition data of cows that were 
not cured form 15 to 45 days after the mastitis 
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Perspectives 
Combinations of different predicted milk components will 
be tested to provide early indicators of risk of mastitis 
 
 
Through the OptiMIR project several European milk 
recording organizations get direct access to MIR data  
 
  
A comprehensive definition of the different mastitis cases 
was performed and will allow performing further 
detailed phenotypic and genetic analysis 
 
  
  MIR milk analysis is a quick and inexpensive method already used in 




  Allows the development and the implementation of novel  
 management tools based on MIR technology 
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